Bioinformatics analysis of single and multi-hybrid epitopes of GRA-1, GRA-4, GRA-6 and GRA-7 proteins to improve DNA vaccine design against Toxoplasma gondii
- 2 Downloads
Toxoplasma gondii, is a causative agent of morbidity and mortality in immunocompromised and congenitally-infected individuals. Attempts to construct DNA vaccines against T. gondii using surface proteins are increasing. The dense granule antigens are highly expressed in the acute and chronic phases of T. gondii infection and considered as suitable DNA vaccine candidates to control toxoplasmosis. In the present study, bioinformatics tools and online software were used to predict, analyze and compare the structural, physical and chemical characters and immunogenicity of the GRA-1, GRA-4, GRA-6 and GRA-7 proteins. Sequence alignment results indicated that the GRA-1, GRA-4, GRA-6 and GRA-7 proteins had low similarity. The secondary structure prediction demonstrated that among the four proteins, GRA-1 and GRA-6 had similar secondary structure except for a little discrepancy. Hydrophilicity/hydrophobicity analysis showed multiple hydrophilic regions and some classical high hydrophilic domains for each protein sequence. Immunogenic epitope prediction results demonstrated that the GRA-1 and GRA-4 epitopes were stable and GRA-4 showed the highest degree of antigenicity. Although the GRA-7 epitope had the highest score of immunogenicity, this epitope was instable and had the lowest degree of antigenicity and half-time in eukaryotic cell. Also, the results indicated that GRA4–GRA7 epitope and GRA6–GRA7 had the highest degree of antigenicity and immunogenicity among multi-hybrid epitopes, respectively. Totally, in the present study, single epitopes showed the highest degree of antigenicity compared with multi-hybrid epitopes. Given the results, it can be concluded that GRA-4 and GRA-7 can be powerful DNA vaccine candidates against T. gondii.
KeywordsBioinformatics analysis Toxoplasma gondii GRA proteins DNA vaccine
We would like to acknowledge the Aja University of Medical Sciences management for supporting us to do this study.
All authors contributed extensively to the present study. M.S, M.E and MR.T designed the study; M.E and MR.T collected and analyzed Data; M.E and M.S wrote the main manuscript. All authors discussed the results and commented on the manuscript at all stages.
Compliance with ethical standards
Conflict of interest
The authors declare that there is no conflict of interest.
This article does not contain any studies with human participants or animals performed by any of the authors.
- Cong H, Mui EJ, Witola WH, Sidney J, Alexander J, Sette A, Maewal A, McLeod R (2010) Human immunome, bioinformatic analyses using HLA supermotifs and the parasite genome, binding assays, studies of human T cell responses, and immunization of HLA-A*1101 transgenic mice including novel adjuvants provide a foundation for HLA-A03 restricted CD8 + T cell epitope based, adjuvanted vaccine protective against Toxoplasma gondii. Immunome Res 6:12CrossRefPubMedPubMedCentralGoogle Scholar
- Couper KN, Nielsen HV, Petersen E, Roberts F, Roberts CW, Alexander J (2003) DNA vaccination with the immunodominant tachyzoite surface antigen (SAG-1) protects against adult acquired Toxoplasma gondii infection but does not prevent maternofoetal transmission. Vaccine 21:2813–2820CrossRefPubMedGoogle Scholar
- Hiszczyńska-Sawicka E, Olędzka G, Holec-Gąsior L, Li H, Xu JB, Sedcole R, Kur J, Bickerstaffe R, Stankiewicz M (2011) Evaluation of immune responses in sheep induced by DNA immunization with genes encoding GRA1, GRA4, GRA6 and GRA7 antigens of Toxoplasma gondii. Vet Parasitol 177:281–289CrossRefPubMedGoogle Scholar
- Lecordier L, Moleon-Borodowsky I, Dubremetz JF, Tourvieille B, Mercier C, Deslée D, Capron A, Cesbron-Delauw MF (1995) Characterization of a dense granule antigen of Toxoplasma gondii (GRA6) associated to the network of the parasitophorous vacuole. Mol Biochem Parasitol 70(1–2):85–94CrossRefPubMedGoogle Scholar
- Martin V, Supanitsky A, Echeverria PC, Litwin S, Tanos T, De Roodt AR, Guarnera EA, Angel SO (2004) Recombinant GRA4 or ROP2 protein combined with alum or the gra4 gene provides partial protection in chronic murine models of toxoplasmosis. Clin Diagn Lab Immunol 11:704–710PubMedPubMedCentralGoogle Scholar
- Meisel R, Stachelhaus S, Mevelec MN, Reichmann G, Dubremetz JF, Fischer HG (1996) Identification of two alleles in the GRA4 locus of Toxoplasma gondii determining a differential epitope which allows discrimination of type versus type II and III strains. Mol Biochem Parasitol 81:259–263CrossRefPubMedGoogle Scholar
- Mévélec MN, Mercereau-Puijalon O, Buzoni-Gatel D, Bourguin I, Chardès T, Dubremetz JF, Bout D (1998) Mapping of B epitopes in GRA4, a dense granule antigen of Toxoplasma gondii and protection studies using recombinant proteins administered by the oral route. Parasite Immunol 20:183–195PubMedGoogle Scholar
- Mozaffarian F, Khoshdel AR, Shaddel M (2014) Threat of toxoplasmosis targeting the brain for military forces and veterans. Arch Mil Med 3:e18560Google Scholar
- Shaddel M, Mehbod ASA, Karamy M (2007) Toxoplasma gondii infection in neonates. Iran J Parasitol 3:34–37Google Scholar